CABOZANTINIB for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where CABOZANTINIB was used for Bladder cancer.
Most Reported Side Effects for CABOZANTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 404 | 10.6% | 71 | 263 |
| Fatigue | 263 | 6.9% | 70 | 175 |
| Malignant neoplasm progression | 238 | 6.2% | 143 | 132 |
| Nausea | 215 | 5.6% | 56 | 157 |
| Decreased appetite | 191 | 5.0% | 44 | 133 |
| Off label use | 190 | 5.0% | 71 | 76 |
| Hypertension | 165 | 4.3% | 14 | 105 |
| Pyrexia | 162 | 4.2% | 24 | 154 |
| Vomiting | 157 | 4.1% | 46 | 127 |
| Asthenia | 153 | 4.0% | 36 | 105 |
| Death | 153 | 4.0% | 153 | 47 |
| Palmar-plantar erythrodysaesthesia syndrome | 144 | 3.8% | 24 | 85 |
| Dyspnoea | 143 | 3.7% | 40 | 125 |
| Sepsis | 130 | 3.4% | 44 | 121 |
| Stomatitis | 126 | 3.3% | 19 | 84 |
Other Indications for CABOZANTINIB
Renal cell carcinoma (1,241)
Hepatocellular carcinoma (437)
Metastatic renal cell carcinoma (292)
Hormone-refractory prostate cancer (170)
Transitional cell carcinoma (136)
Thyroid cancer (125)
Non-small cell lung cancer (101)
Product used for unknown indication (94)
Renal cancer (77)
Medullary thyroid cancer (73)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)